COVID-19 is a life-threatening respiratory disease triggered by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2). It has been considered a pandemic viral infection …

Global efforts to contain the coronavirus disease-2019 (COVID-19) include the development
of novel preventive vaccines and effective therapeutics. Passive antibody therapies using …

The emergence of a new acute respiratory syndrome Coronavirus 2 (SARS‐CoV‐2), the
cause of the 2019‐nCOV disease (COVID‐19), has caused a pandemic and a global health …

Introduction: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) as a
potentially fatal agent for a new emerging viral disease (COVID-19) is of great global public …

The outbreak of COVID-19, the disease caused by infection of the coronavirus SARS-CoV-2
that began in December 2019 in Wuhan, China, has caused more than 2 990 559 confirmed …

The sudden emergence of the novel severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2) causing the coronavirus disease of 2019 (COVID-19) has brought the world …

The newly emerged severe acute respiratory syndrome-related coronavirus-2 (SARS-CoV-
2) has recently caused pandemic Coronavirus Disease-2019 (COVID-19). Considering the …

With the number of Coronavirus Disease 2019 (COVID-19) cases soaring worldwide and
limited vaccine availability for the general population in most countries, the monoclonal …

Monoclonal antibodies are a promising treatment for COVID-19. However, the emergence of
SARS-CoV-2 variants raised concerns about these therapies' efficacy and long-term …

ABSTRACT Coronavirus disease 2019 (COVID-19) was declared as pandemic on March
11th 2020 by the world health organization (WHO). Vaccination is for preventing COVID-19 …